Ischemic cardiomyopathy: endomyocardial biopsy and ventriculographic evaluation of patients with congestive heart failure, dilated cardiomyopathy and coronary artery disease.

OBJECTIVES This study was designed to define clinical and pathophysiologic similarities and differences between patients with ischemic and idiopathic dilated cardiomyopathy. BACKGROUND Significant coronary artery disease in patients with new onset congestive heart failure due to dilated cardiomyopathy has important prognostic and therapeutic implications. METHODS Clinical, histologic, ventriculographic and hemodynamic features of patients with dilated cardiomyopathy who underwent coronary angiography were reviewed. RESULTS Patients with ischemic cardiomyopathy (n = 21) compared with those with idiopathic cardiomyopathy (n = 40) had similar presenting symptoms, durations of illness, and coronary risk factor profiles, with the exception of a greater prevalence of cigarette smoking (71% vs. 39%, p = 0.028) and male gender (100% vs. 70%, p = 0.014). Endomyocardial biopsy specimens from patients with ischemic cardiomyopathy demonstrated a greater prevalence of replacement fibrosis (48% vs. 8%, p = 0.001) and a lesser degree of histologically assessed myocyte hypertrophy (mean grade 0.5 +/- 0.7 vs. 1.3 +/- 1.3, p = 0.015). Although ventriculographically determined regional dyskinesia was present in both groups, there was a higher prevalence of two or more adjacent segments in the ischemic cardiomyopathy group (50% vs. 10%, p = 0.03). This ischemic group had hemodynamic variables associated with a worse prognosis: higher pulmonary artery wedge pressure (23 +/- 10 vs. 15 +/- 9 mm Hg, p = 0.006) and lower cardiac index (2.0 +/- 0.5 vs. 2.3 +/- 0.5 liters/min per m2, p = 0.044). Also, in this group, patients had a mean of 2.6 +/- 0.7 diseased vessels; 15 (71%) of 21 patients had triple-vessel disease and 18 (86%) of 21 had at least one occluded or suboccluded artery. CONCLUSIONS 1) Patients with ischemic and idiopathic cardiomyopathy may be clinically indistinguishable unless coronary angiography is performed. 2) A greater prevalence of replacement fibrosis and a lesser degree of myocardial hypertrophy in patients with ischemic cardiomyopathy may account for the greater extent of hemodynamic decompensation observed at presentation.

[1]  J. Barboriak,et al.  The association of smoking with cardiomyopathy. , 1984, The New England journal of medicine.

[2]  P. Anversa,et al.  Left ventricular failure induced by myocardial infarction. I. Myocyte hypertrophy. , 1985, The American journal of physiology.

[3]  B. Brent,et al.  Coronary artery bypass surgery in patients with left ventricular dysfunction. , 1986, The American journal of medicine.

[4]  J. Parrillo,et al.  Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain. , 1987, Journal of the American College of Cardiology.

[5]  G. Lamas,et al.  Patency of the infarct-related coronary artery and ventricular geometry. , 1991, The American journal of cardiology.

[6]  C. Maynard,et al.  Results of coronary artery surgery in patients with poor left ventricular function (CASS). , 1983, Circulation.

[7]  E L Bolson,et al.  Variability in the measurement of regional left ventricular wall motion from contrast angiograms. , 1983, Circulation.

[8]  H Sandler,et al.  The use of single plane angiocardiograms for the calculation of left ventricular volume in man. , 1968, American heart journal.

[9]  J. Cohn,et al.  Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. , 1983, The American journal of cardiology.

[10]  L. Stevenson,et al.  Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation. , 1991, Circulation.

[11]  Miller Tr,et al.  A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). , 1990, The Journal of rheumatology.

[12]  E. Raftery,et al.  Occlusive disease of the coronary arteries presenting as primary congestive cardiomyopathy. , 1969, Lancet.

[13]  E. Sonnenblick,et al.  Ischemic cardiomyopathy: pathophysiologic mechanisms. , 1990, Progress in cardiovascular diseases.

[14]  W. Kannel,et al.  Clinical features of unrecognized myocardial infarction--silent and symptomatic. Eighteen year follow-up: the Framingham study. , 1973, The American journal of cardiology.

[15]  P. Ganz,et al.  Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.

[16]  U. Förstermann,et al.  Selective Attenuation of Endothelium‐Mediated Vasodilation in Atherosclerotic Human Coronary Arteries , 1988, Circulation research.

[17]  R. A. Johnson,et al.  Dilated cardiomyopathies of the adult (second of two parts). , 1982, The New England journal of medicine.

[18]  V. Fuster,et al.  Reversal of chronic ischemic myocardial dysfunction after transluminal coronary angioplasty. , 1988, Journal of the American College of Cardiology.

[19]  P. Anversa,et al.  Left ventricular failure induced by myocardial infarction. II. Tissue morphometry. , 1985, The American journal of physiology.

[20]  R. A. Johnson,et al.  Cardiomyopathic syndrome due to coronary artery disease. I: Relation to angiographic extent of coronary disease and to remote myocardial infarction. , 1977, British heart journal.

[21]  G. Hutchins,et al.  Infarct expansion: pathologic analysis of 204 patients with a single myocardial infarct. , 1986, Journal of the American College of Cardiology.

[22]  W Grossman,et al.  Cardiac hypertrophy: useful adaptation or pathologic process? , 1980, The American journal of medicine.

[23]  A. Svejgaard,et al.  Letter: Lack of antigen response to myxoviruses in multiple sclerosis. , 1973, Lancet.

[24]  A. Katz.  Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. , 1990, The New England journal of medicine.

[25]  M. Pfeffer,et al.  Myocardial Infarct Size and Ventricular Function in Rats , 1979, Circulation research.

[26]  J. Deanfield,et al.  Direct effects of smoking on the heart: silent ischemic disturbances of coronary flow. , 1986, The American journal of cardiology.

[27]  R. Rosati,et al.  Ischemic cardiomyopathy: the myopathy of coronary artery disease. Natural history and results of medical versus surgical treatment. , 1974, The American journal of cardiology.

[28]  E. Braunwald,et al.  Myocardial Stunning and Hibernation: Mechanisms and Clinical Implication , 1992 .

[29]  R. Virmani,et al.  Congestive heart failure due to coronary artery disease without myocardial infarction: clinicopathologic description of an unusual cardiomyopathy. , 1989, Human pathology.

[30]  W Grossman,et al.  Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. , 1986, Circulation.

[31]  L. Blackbourne,et al.  Coronary Revascularization Rather than Cardiac Transplantation for Chronic Ischemic Cardiomyopathy , 1989, Annals of surgery.

[32]  S. Faulkner,et al.  Ischemic cardiomyopathy: medical versus surgical treatment. , 1977, The Journal of thoracic and cardiovascular surgery.

[33]  S. Scott,et al.  Comparison of medical and surgical treatment for unstable angina pectoris. Results of a Veterans Administration Cooperative Study. , 1987, The New England journal of medicine.

[34]  H. Kay,et al.  Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. , 1987, The American journal of cardiology.

[35]  B. Bulkley,et al.  Ischemic cardiomyopathy: a clinicopathologic study of fourteen patients. , 1980, American heart journal.

[36]  H W Woo,et al.  Advantages and applications of the centerline method for characterizing regional ventricular function. , 1986, Circulation.